Literature DB >> 4558507

Trial of an oral bacterial antigen against common colds.

D A Tyrrell, P S Nolan, S E Reed, M J Healy.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4558507      PMCID： PMC478710          DOI： 10.1136/jech.26.2.129

Source DB:  PubMed          Journal:  Br J Prev Soc Med        ISSN： 0007-1242


× No keyword cloud information.
  4 in total

1.  A trial of bacterial vaccines for the common cold in the Royal Air Force.

Authors:  D L MILLER; J C MCDONALD; R E WILLIAMS; J S WILSON
Journal:  Lancet       Date:  1960-02-13       Impact factor: 79.321

2.  Production of an interferon-like agent following inoculation with bacterial vaccine.

Authors:  M Degre; H Dahl
Journal:  Proc Soc Exp Biol Med       Date:  1971-05

3.  Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum.

Authors:  R G Douglas; R D Rossen; W T Butler; R B Couch
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

4.  CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS.

Authors:  T B TOMASI; E M TAN; A SOLOMON; R A PRENDERGAST
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307
  4 in total
  1 in total

1.  The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.

Authors:  Fulvio Braido; Giovanni Melioli; Piero Candoli; Andrea Cavalot; Mario Di Gioacchino; Vittorio Ferrero; Cristoforo Incorvaia; Carlo Mereu; Erminia Ridolo; Giovanni Rolla; Oliviero Rossi; Eleonora Savi; Libero Tubino; Giorgio Reggiardo; Ilaria Baiardini; Eddi di Marco; Gilberto Rinaldi; Giorgio Walter Canonica; Carlo Accorsi; Claudia Bossilino; Laura Bonzano; Michela DiLizia; Barbara Fedrighini; Valentina Garelli; Vincenzo Gerace; Sara Maniscalco; Ilaria Massaro; Alessandro Messi; Manlio Milanese; Silvia Peveri; Arminio Penno; Stefano Pizzimenti; Tiziana Pozzo; Alberto Raie; Sergio Regina; Francesca Sclifò
Journal:  Immunol Lett       Date:  2014-11-03       Impact factor: 3.685
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.